Bone Biologics Corp (NASDAQ:BBLG) does about 2.07M shares in volume on a normal day but saw 2454681 shares change hands in the recent trading day. The company now has a market cap of 1.44M USD. Its current market price is $2.72, marking no change compared to the previous close of $2.72. The 52 week high reached by this stock is $11.76 whilst the lowest price level in 52 weeks is $1.00.
Bone Biologics Corp (BBLG) has a 20-day trading average at $1.55 and the current price is -76.87% off the 52-week high compared with 172.00% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.47 and its 200-day simple moving average is $2.74. If we look at the stock’s price movements over the week, volatility stands at 28.83%, which increases to 29.59% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 77.86 to suggest the stock is overbought.
The consensus objective for the share price is $19.50, suggesting that the stock has a potential upside of 86.05% over the period.
Bone Biologics Corp (BBLG) stock is up 36.68% over the week and 126.67% over the past month. Its price is -39.82% year-to-date and -74.44% over the past year.
The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -13.52 below consensus estimates by -1.52. The company’s next earnings report forecasts estimating quarterly EPS at -1.39 and -5.32 for whole year.
To reach the target analysts have set, the stock logically needs to grow 86.05 percent from here.
The company has a return on investment of -166.12% and return on equity of -189.37%. Price to book ratio is 0.75.
